A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2011
08/23/2011	US8003363 Purification of vaccinia virus- and recombinant vaccinia virus-based vaccines
08/23/2011	US8003332 Inhibition of membrane fusion proteins
08/23/2011	US8003115 Hybrid immunomodulatory peptide and nucleotide sequences for treating allergies
08/23/2011	US8003114 AbfB-2 gene from Penicillium funiculosum
08/23/2011	US8003113 DNA vaccine compositions and methods of use
08/23/2011	US8003112 Meningococcal and pneumococcal conjugate vaccine and method of using same
08/23/2011	US8003111 Dimeric alpha interferon pegylated site-specifically shows enhanced and prolonged efficacy in vivo
08/23/2011	US8003110 Metalloproteinase oligopeptides and their therapeutic use
08/23/2011	US8003109 Pharmaceutical compositions containing the long pentraxin PTX3
08/23/2011	US8003108 Sclerostin epitopes
08/23/2011	US8003106 Human monoclonal antibodies to influenza M2 protein and methods of making and using same
08/23/2011	US8003105 Method of treating cancer by co-administration of anticancer agents
08/23/2011	US8003104 Method for treating inflammation
08/23/2011	US8003103 High affinity human antibodies to human IL-18 receptor
08/23/2011	US8003102 Anti-CXCR4 antibodies
08/23/2011	US8003101 Inflammatory mediator antagonists
08/23/2011	US8003100 Antibodies that bind to 238P1B2
08/23/2011	US8003099 Antibodies against human IL17 and uses thereof
08/23/2011	US8003098 Methods for damaging cells using effector functions of anti-EphA4 antibodies
08/23/2011	US8003097 Treatment of cerebral amyloid angiopathy
08/23/2011	US8003096 Means and methods for the recruitment and identification of stem cells
08/23/2011	US8003093 B cell-based vaccine loaded with the ligand of natural killer T cell and antigen
08/23/2011	CA2606022C Methods of applying ionization radiation for therapy of hiv infection
08/23/2011	CA2324478C A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
08/23/2011	CA2296807C Erbb4 receptor-specific neuregulin related ligands and uses therefor
08/23/2011	CA2283093C Recombinant chimeric viruses and uses thereof
08/23/2011	CA2270877C Peptide-based immunotherapeutic agent
08/23/2011	CA2270176C Methylated, smd homologous peptides, reactive with the antibodies from sera of living beings affected with systemic lupus erythematosus
08/23/2011	CA2203888C Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
08/23/2011	CA1341620C Envelope antigens of hiv-1
08/18/2011	WO2011100754A1 Live listeria-based vaccines for central nervous system therapy
08/18/2011	WO2011100700A2 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies
08/18/2011	WO2011100636A1 Markers for determination of patient responsiveness
08/18/2011	WO2011100620A2 Upar binding agents and methods of use thereof
08/18/2011	WO2011100565A2 Multimeric proteins comprising immunoglobulin constant domains
08/18/2011	WO2011100538A1 Therapeutic methods using an ti-cd200 antibodies
08/18/2011	WO2011100508A2 Methods and compositions related to glycoprotein-immunoglobulin fusions
08/18/2011	WO2011100489A2 Improved live bacterial vaccine safety
08/18/2011	WO2011100477A2 Antibodies and processes for preparing the same
08/18/2011	WO2011100468A2 Methods and materials for treating cancer
08/18/2011	WO2011100453A2 Compositions and methods for the treatment of cardiac and vascular disease
08/18/2011	WO2011100408A2 Serologic correlates of protection against bacillis anthracis infection
08/18/2011	WO2011100403A1 Cd20 antibodies and uses thereof
08/18/2011	WO2011100398A1 Cd20 antibodies and uses thereof
08/18/2011	WO2011100330A2 Compositions and methods for preventing or treating a human parvovirus infection
08/18/2011	WO2011100151A1 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
08/18/2011	WO2011099882A1 Vaccine compositions and methods of use thereof
08/18/2011	WO2011099881A1 Pharmaceutical compositions containing antibodies to neuropeptide head activator and methods thereof
08/18/2011	WO2011099684A1 Single domain antibody against muc1
08/18/2011	WO2011099524A1 Radioactive metal-labeled anti-cadherin antibody
08/18/2011	WO2011098837A1 Method for the production of stable live vaccine formulations
08/18/2011	WO2011098778A2 Peptides for vaccines against birch allergy
08/18/2011	WO2011098762A2 Antibodies against cxcr4
08/18/2011	WO2011098569A1 Process for producing an allergen extract
08/18/2011	WO2011098520A1 Agonist dr5 binding polypeptides
08/18/2011	WO2011098262A2 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
08/18/2011	WO2011097960A1 Biomarkers of gastric cancer and use thereof
08/18/2011	WO2011097733A1 Free hexasaccharide isolated from several campylobacter species
08/18/2011	WO2011097708A1 Lipidated antigens and use thereof for enhancing an immunological response
08/18/2011	WO2011082388A3 Infectious dna vaccines against chikungunya virus
08/18/2011	WO2011069795A4 Neutralizing prolactin receptor antibodies and their therapeutic use
08/18/2011	WO2011068953A9 Atoxic recombinant holotoxins of clostridium difficile as immunogens
08/18/2011	WO2011060260A3 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
08/18/2011	WO2011049810A3 Compositions and methods for treating inflammation and fibrosis
08/18/2011	WO2011046946A3 Bifunctional molecules with antibody-recruiting and entry inhibitory activity against the human immunodeficiency virus
08/18/2011	WO2011046832A3 Granulysin in immunotherapy
08/18/2011	WO2011044576A3 Selectively disrupted whole-cell vaccine
08/18/2011	WO2011044499A3 Enterotoxigenic e. coli fusion protein vaccines
08/18/2011	WO2011038302A3 Insulin receptor binding antibodies
08/18/2011	WO2011031438A9 Porcine torque teno virus vaccines and diagnosis
08/18/2011	WO2011028963A3 Immunogenic hiv composition
08/18/2011	WO2011019932A3 Compositions and methods for the therapy and diagnosis of influenza
08/18/2011	WO2011000962A9 Hiv related peptides combination or fusion for use in hiv vaccine composition or as diagnostic means
08/18/2011	US20110202000 Anti-amyloid beta antibodies conjugated to sialic acid-containing molecules
08/18/2011	US20110201654 Therapeutic combination
08/18/2011	US20110201092 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the listeria, and methods of use thereof
08/18/2011	US20110201029 Il-13 receptor antibodies
08/18/2011	US20110200990 RECEPTOR ACTIVATOR OF NF kappa-B
08/18/2011	US20110200641 Minor allergen control to increase safety of immunotherapy
08/18/2011	US20110200640 Multivalent antihelminthic vaccine
08/18/2011	US20110200639 Botulinum toxin treatments of Depression
08/18/2011	US20110200638 Bacterial vaccine
08/18/2011	US20110200637 Immunizing Compositions and Methods of Use
08/18/2011	US20110200636 Method for improving the breadth of the immune response to diverse strains and clades of hiv
08/18/2011	US20110200635 Combined influenza vaccines for seasonal and pandemic protection
08/18/2011	US20110200634 Immunogenic formulation
08/18/2011	US20110200633 Cytomegalovirus Surface Protein Complex for Use in Vaccines and as a Drug Target
08/18/2011	US20110200632 Adjuvanting material
08/18/2011	US20110200631 Lawsonia intracellularis vaccines
08/18/2011	US20110200630 Live attenuated virus vaccines for la crosse virus and other bunyaviridae
08/18/2011	US20110200629 Tumor antigen peptide and use thereof
08/18/2011	US20110200628 Chimeric Proteins that Induce Effects Directed Against Viruses
08/18/2011	US20110200627 Anti-cd147 antibodies, methods and uses
08/18/2011	US20110200626 Iqgap3 epitope peptides and vaccines containing the same
08/18/2011	US20110200625 Pharmaceutical composition
08/18/2011	US20110200624 Novel peptides for use in transfection
08/18/2011	US20110200623 Polypeptide complex comprising non-peptidyl polymer having three functional ends
08/18/2011	US20110200622 Polypeptide specifically binding to vascular endothelial growth factor, fusion protein including polypeptide, and methods therefor
08/18/2011	US20110200621 Compositions and methods for treating cancer
08/18/2011	US20110200620 B7-h1 and methods of diagnosis, prognosis, and treatment of cancer

1 ... 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 ... 1823